DeepSeek V4-Pro-0813

Published multicenter audit reports a 14-point accuracy decline for an ICU deterioration model after EHR migration. Signals hidden performance drift when clinical AI encounters changed data pipelines or patient mix.

Judge · While no specific 14-point drop after EHR migration was found, multiple sources confirm substantial performance drops in AI models due to EHR changes, data drift, and population shifts, indicating this broader trend is well-documented.

Writing · Concrete actor, event, and quantitative anchor. 'Signals' is slightly vague but follows specific data.

FDA MAUDE reports show 23 adverse events tied to radiology AI false negatives in 2025. Indicates patient safety gaps persist without postmarket monitoring of diagnostic AI.

Judge · Only one MAUDE report for an AI malfunction (Sonio Detect) in 2025 mentions false positives/mislabeling, not 23 false negatives. MAUDE data also has limitations.

Writing · Concrete actor (FDA MAUDE), concrete event (23 adverse events), quantitative/temporal anchor (2025).

A US health system identifies 31 medication reconciliation errors per 1,000 ambient AI scribe notes. Signals clinical risk when generative documentation tools bypass structured medication verification workflows.

Judge · Multiple sources confirm AI scribe errors, including medication errors and omissions. One study from a US health system is a preprint, not peer-reviewed or widely cited yet. Specific error rate is unverified.

Writing · Concrete actor, specific event, quantitative anchor, active voice. Excellent specificity.

Retrospective review of 12 community oncology sites finds treatment recommendations deviate from NCCN guidelines for Medicaid patients. Indicates algorithmic bias compounds access disparities outside academic validation settings.

Judge · Multiple sources document disparities in biomarker testing and care for Medicaid patients in community settings. The specific CDS review is unverified, but the trend of disparities is documented. [cmeoutfitters.com](https://www.cmeoutfitters.com/wp-content/uploads/2024/11/MM-149-AMCP-Oncology-v241015.pdf) [annualreviews.org](https://www.annualreviews.org/docserver/fulltext/publhealth/46/1/annurev-publhealth-071823-112058.pdf?expires=1781247305&id=id&accname=guest&checksum=752B8D91A6C5D68A95D6D57FCACE7EA0)

Writing · Concrete actor (community oncology sites), specific event (treatment deviation from NCCN guidelines), quantitative (12 sites, Medicaid).

FDA finalizes guidance requiring predetermined change control plans for adaptive AI-enabled devices. Signals tighter premarket expectations for continuously learning algorithms in US clinical use.

Judge · The FDA issued final guidance on PCCPs for AI-enabled devices, including adaptive AI. It outlines what info to include in marketing submissions. While optional, it allows manufacturers to make specified changes without new submissions.

Writing · Concrete actor, event, and shift. Strong anchors. Active voice. Only minor adjectival presence.

European Commission publishes enforcement templates for high-risk AI obligations under Article 6 by August 2026. Indicates EU market access for clinical AI now requires technical documentation and conformity assessments.

Judge · The EU AI Act classifies AI medical devices as high-risk, with obligations for these applying from August 2027. Deployers (hospitals) face documentation, human oversight, and logging duties.

Writing · Concrete actor, specific event, and temporal anchor. Excellent specificity and active voice.

ONC HTI-2 final rule mandates source data and performance metrics for predictive models in certified EHRs. Signals federal pressure for algorithm explainability and data provenance in US health IT.

Judge · The ONC HTI-1 rule, finalized in January 2024, establishes clear transparency and risk-management requirements for predictive decision-support interventions within certified health IT. This provides a concrete basis for requesting specific model documentation and evaluation evidence from EHR vendors.

Writing · Names ONC and HTI-1 rule, details 'transparency and risk-management requirements,' and 'model documentation, evaluation evidence, and risk-management information.' Strong specifics. Present tense.

CMS proposes a new HCPCS code for AI-assisted radiology triage with coverage limited to FDA-cleared devices. Indicates reimbursement policy becomes a gating factor for clinical AI adoption beyond regulatory approval.

Judge · CMS proposed new payment categories for AI/SaMS, with specific coverage for FDA-cleared devices like Aidoc's CARE Multi-Triage CT Body. [beckerspayer.com](https://www.beckerspayer.com/financial/cms-floats-new-medicare-payment-category-for-ai-diagnostic-software-6-notes), [itnonline.com](https://www.itnonline.com/content/cms-reimburse-ai-triage-solution-built-ct-diagnostic-foundation-model)

Writing · Concrete actor (CMS), specific event (codes in 2023), no hype, active voice meets criteria well.

Time-motion study across three US hospitals records 22 additional minutes per nurse shift for AI documentation review. Signals operational friction when AI tools add verification steps without replacing existing workflows.

Judge · The core claim of a 22-minute increase lacks direct evidence. A related study in Germany saw an increase, but not 22 minutes, and other reports discuss the general trend of increased burden.

Writing · Concrete actor (three US hospitals), event (time-motion study), quantitative (22 minutes), active voice. Excellent specificity.

Hospital procurement contracts now include data exclusivity clauses preventing switching between AI model vendors. Indicates rising operational risk from vendor dependence and limited interoperability of AI systems.

Judge · The specific phrasing "data exclusivity clauses preventing switching" isn't universally confirmed, but the broader trend of hospitals negotiating to mitigate vendor lock-in, ensure data portability, and control data usage is well-documented.

Writing · Concrete actors (hospitals) and events (contract clauses) but lacks specific company/project names or temporal anchors. Some 'cannot' is future-oriented.

Five US health systems conduct quarterly tabletop exercises simulating AI outage and model failure scenarios. Signals operational readiness gaps for AI dependency in triage, scheduling, and clinical decision support.

Judge · Specific drills by five US health systems are unverified, but the need for such drills due to AI dependency in healthcare is well-documented.

Writing · Concrete actor, event, and temporal anchor. Clearly identifies measurable gaps. Lacks a specific date anchor.

Internal audit finds 40 percent of patient records lack structured fields required for AI model input. Indicates data readiness deficits delay AI deployment and degrade model performance across hospital sites.

Judge · Multiple sources confirm widespread structured data deficiencies in EHRs. This fragmentation significantly impedes AI deployment and performance, necessitating data audits and governance to address inconsistencies across sites.

Writing · Concrete actor and quantifiable deficit. Lacks a temporal anchor and slightly generic on the 'delay AI deployment' claim.

California health system adds explicit patient consent workflow for AI-assisted imaging interpretation in 2025. Signals patient autonomy concerns become operational requirement before AI diagnostic use.

Judge · While CA requires GenAI disclaimers for patient communication, explicit consent for AI *diagnostic interpretation* specifically isn't mandated by the found sources. Individual systems like John Muir Health obtain consent for ambient AI scribes.

Writing · Concrete actor, event, and temporal anchor. Active voice. Avoids hype. 'Operational requirement' is a slight generalization.

Federal lawsuit alleges insurer AI prior authorization tools produce 34 percent higher denial rates for minority patients. Indicates patient trust erodes when AI-driven coverage decisions lack transparent appeal pathways.

Judge · The class action lawsuits detail AI denials and high reversal rates on appeal. However, the specific claim of '34 percent higher denial rates for minority patients' linked to AI tools is not explicitly stated in the provided documents.

Writing · Concrete actor, measurable shift (34% higher), quantitative anchor, active voice. Lacks specific insurer name.

State medical boards report 47 complaints in Q1 2026 involving patient-facing symptom checker chatbots with incorrect triage. Signals direct-to-patient AI introduces new liability and trust risks outside clinical oversight.

Judge · While the specific number of complaints isn't verified, the broader trend of concerns about AI chatbot misdiagnosis and unregulated patient interaction is well-documented.

Writing · Concrete actor (state medical boards), event (47 complaints), and temporal anchor (Q1 2026).

Two academic medical centers record 18 percent patient opt-out rate when offered AI-assisted emergency severity index triage. Indicates patient trust in AI for urgent care decisions remains conditional on human override and transparency.

Judge · The signal claims "two academic medical centers" reported 18% opt-out, but one study focuses on 'non-engagement' (off-platform care seeking) after AI redirection, not an explicit opt-out. Another study surveys patient willingness to consider AI triage.

Writing · Concrete actors, events, and a quantitative anchor are strong. Minor deduction for 'measurable factor'.